Furness Publishing
Trade publishing for pharmaceutical, medical device and diagnostics industry professionals
Highlights
- New on EvolcAdded 2026-11-16
About Furness Publishing
Furness Publishing produces topic-specific trade publications for the pharmaceutical and medical device industries. Its ONdrugDelivery title covers drug delivery; content is available digitally and in paid print.
The company works with authors, sponsors and advertisers, and its publications are read by people involved in developing, manufacturing and marketing drug delivery and diagnostics products. It is family-owned and based in Lewes, United Kingdom. The registry records its founding in 2013.
Product: Publishes ONdrugDelivery in digital and paid print formats, with a diagnostics publication announced for 2027.
Jobs at Furness Publishing
More media & content companies
Fuse Post
Audio post-production and recording studio services for film and television projects in LondonNew on EvolcFuse Productions
League of Legends casting and live broadcast production for teams, leagues, organisations and communitiesNew on Evolcfusil.uk
Personal website and Fediverse instance for Xander Foster's online presence and publicationsFusion Animation
Medical and scientific animation and interactive learning tools for pharmaceutical, biotech and life sciences organizationsNew on EvolcFuture Publishing
Specialist media brands, content, and advertising technology for consumer and professional audiences and advertisers worldwideRemote-friendlySalary transparentFuture Time Pictures
Film production services for studios and entertainment clients, including behind-the-scenes content and marketing materialsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.